Sign up to receive a recording of this virtual open house that occurred on May 11, 2021.
Hear about planned laboratory expansion & additional capabilities
Learn more about Alcami's US network of laboratories
Listen to the recording of a live Q&A with our Leadership Team
Sign Up Here
PATRICK D. WALSH
CHAIRMAN & CHIEF EXECUTIVE OFFICER
Pat brings over thirty-five years of experience in the healthcare industry directing pharmaceutical manufacturing operations globally in parenteral, API, specialty pharmaceutical, formulation, manufacturing, and analytical contract development organizations. Prior to Alcami, he was co-founder and CEO of TriPharm Services, a parenteral manufacturing business acquired by Alcami. From 2015 to 2019, Mr. Walsh was the Chief Executive Officer of Avista Pharma Solutions, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex in January 2019. Pat was named Chief Executive Officer of AAIPharma Services Corporation in 2010 and led the company through an impressive growth trajectory, culminating in the sale of the company in 2014. Prior executive roles also include CEO of Kadmus Pharma (acquired by Organon) and President and COO of Gensia-Sicor (acquired by Teva).
In addition to his duties at Alcami, Pat serves as Chairman of the Board of specialty pharma company ANI Pharmaceuticals (NASDAQ: ANIP), an independent director of Landec Corporation (NASDAQ: LNDC), and private equity backed Institute Chemica Emiliano (I.C.E.) based in Milan Italy. He is also an Operating Partner at healthcare private equity firm Ampersand Capital. Prior board of director roles includes serving as Chairman of Brammer Bio, MedPharm Ltd, and numerous other pharma and biotechnology companies over the course of his career.
VICE PRESIDENT OF LABORATORY OPERATIONS
Elliott is a world expert in analytical operations with over 18 years of industry experience and a successful track record of leading laboratory operations. Before joining Alcami, he was Vice President and Site Director at Cambrex where he was responsible for leading their Durham, NC site which offers analytical services from R&D through commercial as well as early-phase drug substance development and manufacturing. Prior to this, he was the Executive Director of Analytical Services at Avista Pharma. Elliott received his BS in Biomedical Chemistry from Oral Roberts University and Ph.D. in Chemistry from Northern Illinois University.
Executive director of analytical services
Katie rejoined Alcami in June of 2020 as Executive Director of Analytical Services after spending three years at Avista/Cambrex leading a team to support analytical development and QC testing for drug product development. With 25 years of industry experience, Katie is a proven leader with demonstrated skillsets in customer service, analytical development, lean lab operations, and sustained business growth. Katie holds a Master of Science degree in Chemistry from the University of North Carolina at Wilmington.
director, Site operations
Director, Analytical Operations
Anna was part of the TriPharm team that joined Alcami in January 2020 as Director of Analytical Operations and currently leads our RTP laboratory. Previously, she served as Laboratory Manager at PharMEDium Services/AmerisourceBergen, where she oversaw chemistry, microbiology, and environmental monitoring testing of sterile products. Prior to PharMEDium, Anna held several positions at AAIPharma, Aveva, and Energizer/Hawaiian Tropic Research Laboratories, which encompassed support in research and development, quality control, compliance, remediation efforts, and metrology. Anna received her master’s degree in Chemistry from the University of Gdansk in Poland.
Director, site operations
Joining Alcami (formerly AAIPharma) in 2000, Robert has over 20 years of experience leading world-class laboratory operations. He has held various positions and was instrumental in the development and growth of high-performing teams at several Alcami sites. Robert’s expertise lies in analytical development services, in support of all phases of drug substance/drug product development, from pre-clinical/R&D to post-approval. Prior to Alcami, Robert worked on an NSERC Industrial Research Program in New Analytical Methods and Technologies at the University of Waterloo, CA, where he also earned an M.Sc. degree in Analytical Chemistry.